Thermo Fisher Scientific to acquire Mesa Biotech for $500m to expand point-of-care diagnostics

pharmanewsdaily- January 20, 2021 0

Thermo Fisher Scientific, a global leader in laboratory and diagnostics solutions, has finalized an agreement to acquire Mesa Biotech, a California-based point-of-care molecular diagnostic company, ... Read More